We had previously demonstrated that the cyc-mutant of S49 wild-type lymphoma cells both desensitizes and undergoes a sequestration-internalization of the f-receptor in response to short-term treatment with adrenaline. The cyc-mutant of S49 wild-type lymphoma cells lacks the as subunit ofthe stimulatory coupling protein Ns, but has fully functional Ni, the inhibitory component of the regulatory complex. This suggested that functional Ns was not required for desensitization. To examine the role of Ni in desensitization, both S49 wild-type and cyc-cells were treated with islet-activating protein under conditions that led to over 85% attenuation of Ni function in S49 wild-type cells and approx. 50% attenuation of Ni function in cyc-cells.
INTRODUCTION
Our demonstration that adrenaline desensitized the cyc-variant of S49 wild-type lymphoma cells led to the conclusion that neither functional stimulatory coupling proteins nor increased cyclic AMP was required for homologous desensitization . More recently it has been shown that sequestration of the fl-receptor also occurs in cyc-cells, as measured by an adrenaline-induced shift in cyc--cell fl-receptors to a light-vesicle fraction (Clark et-al., 1985a) , and by the isoprenaline-induced loss of surface receptors on intact cyc-cells (Staehelin & Hertel, 1983; Mahan et al., 1985) .
The recent discoveries (i) that cyc-cells have a functional inhibitory coupling protein (Ni) (Hildebrandt et al., 1982; Jakobs et al., 1983) , (ii) that the fly subunit of Ni from erythrocytes and rabbit liver is probably identical with the fly subunit of N. Manning & Gilman, 1983) , and (iii) that the purified turkey erythrocyte fi-adrenergic receptor is capable of stimulating purified rabbit liver Ni GTPase activity in reconstituted vesicles, led to the suggestion by Asano et al. (1984) that either Ni or the fly subunits may be involved in desensitization. Preliminary results from several laboratories have suggested that Ni may play a role in glucagon-induced desensitization of hepatocytes (Heyworth et al., 1984) and the MDCK cell line (Rich et al., 1984 Katada & Ui, 1982) . Several groups have shown that both the wild-type and cyc-S49 lymphoma cells lose Ni function after IAP treatment Jakobs et al., 1983) . We found that neither the extent of desensitization ofadrenaline-stimulated adenylate cyclase nor the sequestration of the ,-adrenergic receptor appears to be altered by IAP, supporting and extending the previous conclusion that functional coupling proteins are not required orinvolved in homologous desensitization of lymphoma cells. A preliminary report of these results has been published (Clark et al., 1985b) .
Toshiaki Katada, Hokkaido University, Sapporo 060, Japan. IAP was stored in 0.1 M-K2HPO4/KH2PO4, pH 7.4, with 2 M-urea, and controls received the appropriate dilution of this buffer (Katada & Ui, 1982) . After IAP pretreatment, the cells were collected and suspended at a density of 30 x 104-40 x 106 cells/ml in serum-free medium containing 20 mM-Hepes, pH 7.4. Cells were then treated at 37°C for 30 min with 1 /uM-adrenaline in 0.1 mM-ascorbate and 1.0 mM-thiourea, or with only the ascorbate/thiourea. After the hormone treatment, the cells were rapidly cooled to 0-4 0C and collected by centrifugation at 600 g for 5 min. The cells were then washed, and lysed, and the 600 g supernatant was fractionated on sucrose gradients (19-45 %, w/w) as previously described (Clark et al., 1985a ).
Measurement of fi-adrenergic receptors
The distribution of f-receptors in the various sucrose-gradient fractions was determined by
[125I]iodopindolol (IPIN) binding. IPIN was prepared by iodination of I-pindolol as described previously (Barovsky & Brooker, 1980) . Samples (50#tl) of the gradient fractions were incubated with approx. 500 pM-IPIN in 10 mM-Tris/HCl (pH 7.5)/5 mM-MgCl2 for 30 min at 30°C in a final volume of 100 ,u. The incubation was stopped by the addition -of 3 mnl of ice:cold, buffer followed by filtration on Whatman GF/C filters. Adenylate cyclase assay This was measured by the procedure of Salomon et al. (1984) . The assay solution comprised 40 mM-Hepes, pH 7.7, 2 mM or 6 mM-MgCl2, 0.2 mM-ATP, 1 mM-EDTA, 8 mM-phosphocreatine, 16 units of creatine kinase/ml, 0.1 mM-3-isobutyl-1 -methylxanthine, 2-3 gCi of [a_32P]ATP, and 30 gcl of the appropriate heavy-vesicle fraction in a final volume of 100 ,l: 2 mM-MgCl2 was used to assess the effect of IAP on inhibitions by p[NH]ppG and somastatin, and 6 mM-MgCl2 was used for all other assays. Incubations were carried out for 10 min at 30 'C. Reconstitution of cyc--cell membranes Heavy vesicle fractions from cyc-cells (fractions 18-22) were reconstituted by a modification of the Sternweis & Gilman (1979) procedure as previously described (Clark et al., 1984a ). The reconstituted samples were then assayed for adrenaline-stimulated adenylate cyclase activity.
Intact-cell studies
The effect of adrenaline on intact cells was determined by the prelabelling techniques previously described (Butcher, 1978 In the experiments with wild-type cells (b), the dye front migrated off the gel. The lanes shown above were as follows. (Fig. 2) . (Figs. 3a and 3b ). The IAP pretreatment had no effect on either the redistribution or the total number of f-receptors. To determine whether or not the adenylate cyclase of wild-type cells was desensitized after the various pretreatments, heavy-peak sucrose-gradient fractions 18-22 were collected and assayed over a range of adrenaline concentrations (Fig. 4) . Eadie-Hofstee transformations of the data revealed that the typical 3-fold adrenaline-induced increase in Kact. and decrease in Vma.
was not altered by lAP pretreatment. A summary of three experiments identical with that in Fig. 4 cells was followed as a function of the time of treatment with 20 nM-adrenaline (Fig. 5) . Within 2 min cyclic AMP concentrations had reached a maximum, after which they decayed to near-basal values. The shape of the curves was unaltered by IAP, as best shown in the normalized data (inset to Fig. 5) , although, as in the cell-free measurements, the IAP pretreatment did lead to a greater adrenaline stimulation of adenylate cyclase. It has been previously shown by Barber & Butcher (1982) that the decrease in cyclic AMP in intact wild-type cells from peak values is not due to activation of phosphodiesterase, but rather to desensitization. This was determined by two separate procedures: the double-label procedure and the measurement of the decrease in cyclic AMP after addition of propranolol. In the present experiments we found that the rate of the decrease in cyclic AMP after addition of propranolol was unaffected by IAP (results not shown).
DISCUSSION
In wild-type cells, IAP induced the loss of over 85% of the somatostatin and p[NH]ppG inhibition of adenylate cyclase and eliminated ADP-ribosylation of Ni in membranes. In spite ofthe ratherconsiderable attenuation of Ni function, adrenaline-induced desensitization of adenylate cyclase and sequestration of the f-receptor proceeded normally. Since desensitization of adenylate cyclase in cell-free assays and sequestration-internalization are only observed after treatment of the wild-type cells with relatively high concentrations of adrenaline (> 50 nM), it was necessary to monitor the effect of IAP on the desensitization of wild-type cells at a low concentration of adrenaline (20 nM). The data (Fig. 5) indicate that, although IAP produced its characteristic augmentation of adrenaline-stimulated activity, desensitization was not affected. Our results suggest that a functional Ni is not required for the early rapid homologous adrenaline-induced desensitization and sequestration-internalization of the fl-adrenergic receptor in the S49 wild-type lymphoma cells and the cyc-variant.
The conclusion that functional Ni is not required for desensitization is supported by preliminary results from our laboratory, which indicate that homologous adrenaline-induced desensitization ofWI-38 fibroblasts was also unaffected by IAP pretreatment. The IAP treatment was of sufficient duration to eliminate the muscarinic inhibition of cyclic AMP accumulation in these cells. of sensitization or desensitization (sensitization if N1 activation was prevented; desensitization if Ni was activated), but they do not appear to be involved in either adrenaline-induced homologous desensitization of lymphoma cells and fibroblasts or prostaglandin E1-induced heterologous desensitization offibroblasts. Since the glucagon desensitization of hepatocytes is altered by IAP pretreatment (Heyworth et al., 1984) , it seems likely that the mechanisms of desensitization of these cells by glucagon differ from those of the fl-adrenergic receptor in lymphoma cells and fibroblasts. This is supported by the observations that short-term glucagon pretreatment leads to an increase in p[NH]ppG-stimulated adenylate cyclase activity (Heyworth & Houslay, 1983) , whereas long-term treatment actually leads to heterologous desensitization; i.e. adrenaline-, NaF-and p[NH]ppGstimulated activities are decreased (Noda et al., 1984) . Further preliminary evidence suggests that the glucagon desensitizationdoesnotinvolveintemalization (Heyworth & Houslay, 1983; Noda et al., 1984) . Adrenaline desensitization of hepatocytes, by contrast appears to be a typical homologous fi-adrenergic-receptor desensitization (Noda et al., 1984) . Why IAP treatment leads to an increased response in adrenaline in both intact wild-type cells and cell-free assays is not understood. However, it is a general phenomenon, and it has been suggested that this may be the result of the loss of a fl-receptor-Ni interaction (Itoh et al., 1984) . Abramson et al. (1985) have presented preliminary evidence that GTP decreases the affinity of direct agonist binding to S49 cyc--cell lymphoma membranes, using [3H]hydroxybenzylisoprenaline. Since it appears that cyc-cells lack a functional as, the GTP effect on agonist binding could reflect a fl-receptor-Ni interaction. This is indirectly supported by the demonstration that turkey fl-receptor stimulates N1 GTPase activity (Asano et al., 1984) . These data could explain the increase in adrenaline stimulation after IAP treatment of wild-type cells. However, it is equally plausible that it is due to the loss of a basal inhibitory activity of N1; that is, GTP, which must be present for N8-mediated stimulation, activates Ni as well, and loss of this activation after IAP treatment would promote hormone stimulation. Further extrapolation from these results must await the direct assessment of the capacity of the fl-receptor from lymphoma cells to interact with ADP-ribosylated Ni or the fly subunits. Also, since Ni
